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Summary
 
Mice expressing the immunoglobulin (Ig) heavy (H) chain variable (V) region from a rear-
ranged V
 
H
 
12 gene inserted into the IgH locus generate predominantly B-1 cells, whereas ex-
pression of two other V
 
H
 
 region transgenes (V
 
H
 
B1-8 and V
 
H
 
glD42) leads to the almost exclu-
sive generation of conventional, or B-2, cells. To determine the developmental potential of B
cells bearing two distinct B cell antigen receptors (BCRs), one favoring B-1 and the other fa-
 
voring B-2 cell development, we crossed V
 
H
 
12 insertion mice with mice bearing either V
 
H
 
B1-8
or V
 
H
 
glD42. B cells coexpressing V
 
H
 
12 and one of the other V
 
H
 
 genes are readily detected in
the double IgH insertion mice, and are of the B-2 phenotype. In mice coexpressing V
 
H
 
12,
V
 
H
 
B1-8 and a transgenic 
 
k
 
 chain able to pair with both H chains, double H chain–expressing
B-2 cells, and B-1 cells that have lost V
 
H
 
B1-8 are generated, whereas V
 
H
 
B1-8 single producers
are undetectable. These data suggest that B-1 but not B-2 cells are selected by antigenic stimuli
in whose delivery BCR specificity and surface density are of critical importance.
Key words: B-1 cells • B-2 cells • immunoglobulin heavy chain • allelic inclusion • gene 
targeting
 
T
 
wo major B cell subsets, designated B-1 and B-2, exist
in humans and mice. B-1 and B-2 cells can be distin-
 
guished by their cell surface phenotypes and anatomical
localization. B-1 cells, found mainly in the pleural and
peritoneal cavities, express high levels of surface IgM, low
levels of B220 and IgD, and moderate levels of CD5. In
addition, they do not express CD23. In contrast, conven-
tional, or B-2, cells are the predominant B cells found in
the spleen and lymph nodes; they express high levels of
B220, IgD, and CD23 and moderate levels of IgM, and
lack surface CD5 expression (for review see references 1, 2).
Different V
 
H
 
 genes are preferentially expressed in B-1
and B-2 cells (3, 4). The distinct V
 
H
 
 repertoire that is found
in B-1 cells has led to the hypothesis that the specificity
of the B cell antigen receptor (BCR)
 
1
 
 may in fact deter-
 
mine the differentiation of B cells into this subset (5, 6).
It is known that antibodies that react with phosphatidyl
choline (PtC) are produced largely by B-1 cells (7) and are
mostly encoded by either of two H and L chain combina-
tions, namely V
 
H
 
12 and V
 
k
 
4 or V
 
H
 
11 and V
 
k
 
9. Consistent
with the view that BCR specificity plays a role in the de-
velopment of B-1 cells, transgenic mice expressing V
 
H
 
12
alone, or in combination with V
 
k
 
4, generate mostly B-1
cells in all of the peripheral lymphoid organs, including
spleens and lymph nodes (8).
We have generated by gene targeting various strains of
Ig H chain insertion mice carrying different H chain vari-
able (V) region genes targeted into their physiological posi-
tion in the IgH locus. The inserted V
 
H
 
D
 
H
 
J
 
H
 
 elements in-
clude the segments designated V
 
H
 
12 (8), V
 
H
 
B1-8 (9), and
V
 
H
 
glD42 (10). Similar to conventional V
 
H
 
12 transgenic
mice, V
 
H
 
12 insertion mice develop mainly B-1 cells. In
contrast, mice whose IgH alleles were engineered to ex-
press V
 
H
 
B1-8 or V
 
H
 
glD42 develop mainly B-2 cells. This
again suggests that BCR specificity may play a determining
role in the differentiation of B-1 cells. If indeed signals
transmitted through a BCR of a certain specificity lead to
the generation of B-1 cells, then interference with the cell
surface expression of that specific BCR may alter the dif-
ferentiation process of these cells. Here, we generated IgH
double (V
 
H
 
12 and V
 
H
 
B1-8 or V
 
H
 
12 and V
 
H
 
glD42) inser-
tion mice to test whether the expression of a second H
chain in V
 
H
 
12-expressing B cells may act in a dominant
negative manner to perturb the generation of B-1 cells.
 
1
 
Abbreviations used in this paper:
 
 BCR, B cell receptor; Id, idiotype; PtC,
phosphatidyl choline; tg, transgenic. 
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Materials and Methods
 
Mice.
 
The B1-8f (11) and glD42i (10) IgH insertion mice
were generated in the laboratory in Cologne and in collaboration
with D. Eilat’s group at Hebrew University (Jerusalem, Israel),
and have been described previously (references 10 and 11, as in-
dicated behind each mouse strain). The generation of the V
 
H
 
12f
mice will be described elsewhere (Lam, K.-P., and K. Rajewsky,
manuscript in preparation). The conventional V
 
k
 
4 transgenic
mice (8) were obtained from Stephen Clarke (University of
North Carolina, Chapel Hill, NC). Mice used were 2–4 mo old
and maintained in a conventional animal facility.
 
Antibodies.
 
The following mAbs used in this study were pro-
duced and conjugated to fluorochromes in our laboratory: anti-
B220 (RA3-6B2); anti-IgM (R33-24.12); anti-IgD (1.3-5); anti-
CD43 (S7); anti-
 
m
 
a
 
(RS3.1); anti-
 
m
 
b
 
 (MB86); anti–V
 
H
 
B1-8
(Ac146); and anti-V
 
H
 
12 (5C5). The anti-CD5 and anti-CD23
mAbs were purchased from PharMingen.
 
FACS
 
®
 
 Analyses and Cell Sorting.
 
Tissues and cell prepara-
tions for flow cytometric analyses and cell sorting were prepared
as previously described (12). In brief, spleen cells were prepared
by dissociation between frosted glass slides. Peritoneal cavity and
bone marrow cells were obtained by injecting staining medium
(PBS containing 3% FCS and 0.1% NaN
 
3
 
) into the peritoneal
cavity and femurs and tibia, respectively, using a 1-ml syringe
with a 26-gauge needle. All cells were treated with RBC lysing
solution (0.15 M NH
 
4
 
Cl, 1 mM KHCO
 
3
 
, and 0.1 mM
Na
 
2
 
EDTA) to eliminate erythrocytes. For FACS
 
®
 
 analyses, cells
were stained with optimal amounts of FITC-, PE-, and biotin-
conjugated mAbs for 10 min on ice and washed three times with
staining medium. Biotin-conjugated mAbs were revealed with
streptavidin-Cychrome. Flow cytometry analyses were per-
formed on a FACScan™ (Becton Dickinson) and cell sorting was
done on a FACStar
 
PLUS™
 
.
 
Southern Blot Analysis.
 
Genomic DNA was prepared from
mouse livers and sorted splenic B cells (13), digested with BamHI
and fractionated on a 1% agarose gel. After capillary transfer, the
membrane was hybridized with a random-primed 
 
a
 
-P
 
32
 
–labeled
specific probe, as shown in Fig. 5.
 
Results
 
Different B Cell Populations Are Generated in glD42i, B1-
8f, and V
 
H
 
12f Mice.
 
We used gene targeting to generate a
series of IgH insertion mice in which the J
 
H
 
 locus was re-
placed by distinct V
 
H
 
D
 
H
 
J
 
H
 
 segments (14). These segments
were taken from the 4-hydroxy-3-nitrophenyl acetyl–
binding antibody, B1-8 (9); the antibody glD42, which is a
reduced affinity mutant of the DNA-binding antibody,
D42 (10); and the anti-PtC antibody, V
 
H
 
12 (8). The corre-
sponding mice were designated B1-8f, glD42i, and V
 
H
 
12f
respectively. The B1-8f (11) and glD42i (10) mice have
been described previously, whereas the generation of the
V
 
H
 
12f mice will be described elsewhere (Lam, K.-P., and
K. Rajewsky, manuscript in preparation).
Flow cytometric characterizations of the B cell popula-
tions in the spleens of wild-type, glD42i, B1-8f, and V
 
H
 
12f
mice are depicted in Fig. 1. The majority of the B cells
Figure 1. Phenotype of splenic B cells in (A) wild-type, glD42i/1, VH12f/1, and VH12f/glD42i; and (B) B1-8f/1, VH12f/1, and VH12f/B1-8f IgH
insertion mice. Spleen cells obtained from wild-type and various Ig H chain insertion mice were stained with fluorochrome-conjugated allotypic (A, top)
and idiotypic (B, top) antibodies as well as antibodies that recognize various cell surface markers used to define B-1 and B-2 cells. Numbers indicate per-
centage of total lymphocytes in the top panels and percentage of total B2201 cells in the others. 
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present in glD42i (Fig. 1 A) and B1-8f (Fig. 1 B) mice are
B-2 cells in that they express high levels of CD23 (shown
for glD42i mice), IgD (shown for B1-8f mice), and B220,
the pan-B cell marker. In addition, they do not express
CD5, a marker found on T and B-1 cells. In contrast,
V
 
H
 
12f mice generate cells predominantly of the B-1 phe-
notype in that they express intermediate levels of CD5, low
levels of B220 and IgD, and no detectable CD23. These
data are consistent with a previous report that showed the
preferential generation of B-1 cells in the lymphoid organs
of conventional V
 
H
 
12-transgenic mice (8). Thus, different
V
 
H
 
 gene specificity seems to bias the generation and/or se-
lection of different B cell subsets in the mouse.
 
V
 
H
 
12-expressing B Cells Bearing a Second In-frame V Region
Gene Develop into Conventional B Cells.
 
B cell develop-
ment under the condition of H chain allelic inclusion had
previously been analyzed in mice bearing V
 
H
 
B1-8 and
V
 
H
 
glD42 (15). In these double IgH insertion mice, B cells
expressing two functional V
 
H
 
 alleles are readily generated
in the bone marrow and are not counter-selected in the pe-
ripheral lymphoid organs. Here, we cross V
 
H
 
12f mice with
glD42i and B1-8f mice to examine the developmental po-
tential of B cells bearing two distinct BCRs, one that is
preferentially expressed in B-1 and the other in B-2 cells.
Expression of the V
 
H
 
12 and glD42 alleles in B cells can
be identified by the expression of their constant regions as
the former is of the 
 
a
 
 and the latter, of the 
 
b
 
 allotype. Flow
cytometric analyses of the B cells in double V
 
H
 
12f/glD42i
mice revealed that the majority of the cells in the spleen
(Fig. 1 A), bone marrow, and lymph nodes (data not
shown) of these mice coexpress both V
 
H
 
 genes. Similar re-
sults were also obtained when V
 
H
 
12f mice were crossed
with B1-8f mice. Expression of V
 
H
 
12 and V
 
H
 
B1-8 can be
distinguished by staining with the anti-idiotype (Id) mAb
5C5 (8) and Ac146 (9) respectively. The 5C5 mAb recog-
nizes V
 
H
 
12 independent of the L chains (8) whereas the
Ac146 mAb recognizes V
 
H
 
B1-8 in association with 
 
l
 
 and
the majority (
 
z
 
80%) of the 
 
k
 
 L chains (9). As shown in
Fig. 1 B, the majority of the splenic B cells in V
 
H
 
12f/B1-8f
mice coexpress both Ids, indicating that they are double-
IgH expressors. This is also true for the B cells in the bone
marrow and lymph nodes of these mice (data not shown).
Taken together, these data indicate that V
 
H
 
12-expressing B
cells can coexpress another V
 
H
 
 gene.
Surprisingly, phenotypic characterization of the IgH
“double-producers” in V
 
H
 
12f/glD42i and V
 
H
 
12f/B1-8f
mice revealed that these B cells express high levels of B220
and IgD (shown for V
 
H
 
12f/B1-8f mice; Fig. 1 B); and the
majority of them are also CD23-positive (shown for
V
 
H
 
12f/glD42i mice; Fig. 1 A). In addition, these double-
producers do not express CD5 on their cell surfaces. Thus,
in contrast to B cells that express V
 
H
 
12 only, B cells that
coexpress V
 
H
 
12/V
 
H
 
glD42, or V
 
H
 
12/V
 
H
 
B1-8 assumed a
phenotype that is characteristic of B-2 cells.
Development of B Lymphocytes that Coexpress VH12 and
VHB1-8 into Conventional B-2 Cells Is Not Due to Restricted
Light Chain Usage. The specificity of the BCR is deter-
mined by the variable regions of the H and L chains. Thus,
the loss of the B-1 phenotype in cells coexpressing VH12
and VHB1-8 or VH12 and VHglD42 may be due to altered
Ig L chain usage. It is conceivable that the L chains that
associate with both VH12 and VHB1-8 or VH12 and
VHglD42 under the condition of H chain allelic inclusion
are different from those that normally associate with VH12
alone. This altered L chain usage could affect the specificity
of the VH12 receptor and thus could influence the genera-
tion and/or selection of B-1 cells. To examine this possibil-
ity, we crossed Vk4 L chain transgenic (tg) mice (8) with
VH12f/1, B1-8f/1, and VH12f/B1-8f mice. The Vk4
gene used in the generation of the transgenic mice was ini-
tially isolated from a CD51 B lymphoma cell line that to-
gether with VH12 recognizes PtC (8). In addition, this Vk4
L chain can also associate with the B1-8 H chain to form a
BCR of innocuous specificity. Association of the Vk4 L
chain with either or both VH12 and VHB1-8 is demon-
strated in Fig. 2. We had previously shown that the bone
marrow pre-B cell compartment is absent in Ig transgenic
mice whose H and L chains pair to form a BCR of an in-
nocent specificity (16). This probably reflects the fact that
precursor cells carrying functional Ig H and L chain trans-
genes rapidly differentiate into IgM1 B cells. We have used
this phenomenon to examine the association of Vk4 with
both VH12 and VHB1-8. As shown in Fig. 2, B2201
Figure 2. Association of the Vk4 L chain with the VH12 and VHB1-8
H chains. Bone marrow cells from wild-type, VH12f/1, B1-8f/1, or
VH12f/B1-8f mice with or without the Vk4 L chain transgene were
stained with anti-B220, anti-CD43, and anti-IgM mAbs. The figure de-
picts the surface IgM2 cells and the boxed area indicates the pre-B cell
compartment in the bone marrow. Numbers indicate percentage of total
lymphocytes.474 BCR Specificity and Surface Density in B-1 Cell Development
CD432 pre-B cells are present in wild-type and in the var-
ious single and double IgH tg mice and represent z8% of
the cells present. However, this population is fivefold re-
duced in the B1-8f/1, VH12f/1, and B1-8f/VH12f H
chain tg mice that also carry the Vk4 L chain transgene.
This suggests that the Vk4 L chain can associate efficiently
with both VHB1-8 and VH12. Association of Vk4 with
VHB1-8 is also evident in the splenic B cell population of
B1-8f/1, Vk4tg mice, as the cells expressing this H and L
chain combination are all Ac146 Id1 (Fig. 3, top).
Phenotypic analyses of splenic B lymphocytes in B1-8f/1,
Vk4tg mice indicate that these cells are predominantly B-2
cells (Fig. 3, top) as they are B220high(hi), IgDhi, and CD51.
In comparison, splenic B cells present in VH12f/1, Vk4tg
mice are of the B-1 phenotype as indicated by their lower
levels of B220 and IgD expression. Furthermore, these cells
are CD51 (Fig. 3, bottom), in agreement with previous
published data (8).
Interestingly, two populations of B cells are present in
the spleens of VH12f/B1-8f, Vk4tg mice (Fig. 3, middle).
The Ac14615C51 population (fraction a) represents double
producers that coexpress VH12, Vk4, and VHB1-8, Vk4 re-
ceptors. The Ac14625C51 population (fraction b) seems to
have lost the surface expression of the B1-8 H chain and
appears to express only VH12, Vk4. In contrast, Ac1461
5C52 cells (fraction c) that express only VHB1-8, Vk4 are
not seen in these mice.
FACS® analyses of the Ac14615C51 double producers
indicate that these cells are conventional B cells in pheno-
type, as they express high levels of B220 and IgD and lack
CD5 expression. They are indistinguishable from the B
cells found in B1-8f/1; B1-8f/1, Vk4tg; or VH12f/B1-8f
and VH12f/glD42i mice. Thus, the development of alleli-
cally included VH12-expressing B lymphocytes into conven-
tional B cells is not likely to be due to altered L chain us-
age, as it occurs also in the presence of the Vk4 transgene.
B Cells Expressing VH12 only in VH12f/B1-8f Mice Have
Lost the B1-8f Allele. The Ac14625C51 B cells present in
the spleens of VH12f/B1-8f, Vk4tg mice appear to have
lost the surface expression of the B1-8 H chain. Thus, they
are de facto single VH12, Vk4 expressors and, not surpris-
ingly, have a B-1 phenotype (Fig. 3, middle).
Further analyses revealed that B cells expressing VH12
only can also be found in the peritoneal cavities of VH12f/
B1-8f (Fig. 4) and VH12f/glD42i (data not shown) mice
that do not carry the Vk4 L chain transgene. As shown in
Fig. 4, the Ac14625C51 cells comprise a large fraction
(.90%) of the B cells present in the peritoneal cavity of
Figure 3. B cells coexpressing VH12, Vk4, and
VHB1-8, Vk4 assume a conventional B cell pheno-
type. Phenotype of the various splenic B cell popu-
lations found in B1-8f/1, Vk4tg; VH12f/1,
Vk4tg; and VH12f/B1-8f, Vk4tg mice. Cells were
stained with antiidiotypic Ac146 and 5C5 mAbs,
and with anti-B220, anti-IgD, and anti-CD5
mAbs. Numbers indicate percentage of total splenic
lymphocytes.
Figure 4. B cell populations found in the peritoneal cavity of B1-8f/1,
VH12f/1, and VH12f/B1-8f mice. Peritoneal cavity cells of the various
single and double IgH insertion mice were stained with antiidiotypic
Ac146 and anti-IgM (top) and Ac146 and 5C5 (bottom) mAbs. Numbers
indicate percentage of total lymphocytes.475 Lam and Rajewsky
these mice and possess, as expected, a B-1 cell phenotype
(data not shown). Although we cannot exclude the possi-
bility that cells bearing VHB1-8 but not expressing the
Ac146 Id (due to pairing with certain L chains) are also in-
cluded in this population, such cells should represent a mi-
nor fraction. This is supported by FACS® analysis of control
B1-8f/1 mice (Fig. 4), which suggests that the majority of
the B cells (.80%) in the peritoneal cavity express the
Ac146 Id.
To determine the nature of the lack of B1-8 gene
expression in these VH12-only cells, we first sorted
5C51Ac1462 cells from the spleen of VH12f/B1-8f, Vk4tg
mice and analyzed the targeted IgH loci by Southern blot-
ting using a probe located 59 of the DQ52 region. The
wild-type, targeted VH12f and B1-8f alleles should yield
fragment sizes of 2.3, 3.4, and 13.5 kb (Fig. 5, A and B,
lanes 1–3), respectively. In the 5C51Ac1462 B cells sorted
from the spleen of VH12f/B1-8f, Vk4tg mice, the band
corresponding to the targeted B1-8f allele is missing (Fig. 5
B, lane 4), suggesting that the gene has been replaced. Sim-
ilar results were also obtained from 5C51Ac1462 B cells
isolated from the peritoneal cavities of VH12f/B1-8f mice
(data not shown). Thus, 5C51Ac1462 B cells in the spleens
and peritoneal cavity of VH12f/B1-8f, Vk4tg or in the
peritoneal cavity of VH12f/B1-8f have lost VHB1-8 and
consequently express only VH12. Loss of the B1-8f allele
could occur by rearrangement of upstream V or D gene
segments into the B1-8 VDJ and resulting in a nonfunc-
tional allele (17–19). It is not known presently at which de-
velopmental stage the replacement of the B1-8f allele oc-
curs. FACS® analyses of the bone marrow of VH12f/B1-8f
or VH12f/B1-8f, Vk4tg mice suggest that the immature
and mature B lymphocytes in this compartment are pre-
dominantly double producers (data not shown).
Reduced Expansion of B Lymphocytes in Mice Coexpressing
VH12 and Another H Chain. Assessment of the number of
B cells in wild-type and various IgH insertion mice re-
vealed that VH12-expressing B lymphocytes undergo pro-
nounced cellular expansion. As shown in Table I, VH12f/1
mice kept in a conventional animal facility generally have
2- and 20-fold more B cells in the spleen and peritoneal
cavity respectively, compared with wild-type, B1-8f/1, or
glD42i/1 mice. Interestingly, the number of splenic B
cells in mice coexpressing VH12 and either VHB1-8 or
VHglD42 is similar to that in wild-type, B1-8f/1, or
glD42i/1 mice, suggesting that the expansion of VH12-
expressing B cells is curtailed in these mice. However, the
number of peritoneal B cells in VH12f/B1-8f or VH12f/
glD42i mice is similar to that in VH12f/1 mice. This prob-
ably reflects the fact that the B cells that accumulate in the
peritoneal cavities of the double IgH insertion mice are
mainly VH12 expressors (see Fig. 4) that have lost expres-
sion of the other H chain (see Fig. 5).
The presence of a Vk4 L chain transgene leads to an
even greater increase in the number of splenic B cells as
VH12f/1, Vk4tg mice have threefold more cells than do
VH12f/1 mice and eightfold more cells than do either
Vk4tg or B1-8f/1, Vk4tg mice. This is probably due to
Figure 5. Single VH12, Vk4–expressing
B cells in VH12f/B1-8f, Vk4tg mice have
lost the targeted B1-8f H chain allele. (A)
Structures of the wild-type IgH locus (1),
the targeted locus bearing the B1-8 VDJ (2),
and the targeted locus bearing the VH12
VDJ (3) are shown together with the size of
the respective restriction fragments. Genomic
DNA was digested with BamHI and hybrid-
ized with the indicated probe. Maps are not
drawn to scale. (B) Southern blot analysis of
DNA from livers of B1-8f/1, Vk4tg (lane
1); VH12f/1, Vk4tg (lane 2); and VH12f/
B1-8f, Vk4tg (lane 3) mice; and FACS®
sorted 5C51Ac1462 splenic B cells of
VH12f/B1-8f, Vk4tg mice (lane 4). 
Table I. Number of B Cells in the Spleen and Peritoneal Cavity of 
Wild-type and Various Ig tg Mice
Genotype Spleen (3 107)
Peritoneal cavity
(3 106)
1/1 2.45 6 0.83 0.85 6 0.28
VH12f/1 5.76 6 0.26 15.40 6 6.72
B1-8f/1 2.47 6 0.42 0.24 6 0.11
glD42i/1 1.08 6 0.47 0.76 6 0.26
VH12f/B1-8f 2.00 6 0.13 11.63 6 0.38*
VH12f/glD42i 1.60 6 0.21 10.58 6 0.32*
1/1 Vk4tg 2.20 6 0.69 0.95 6 0.33
B1-8f/1 Vk4tg 1.60 6 0.40 0.31 6 0.10
VH12f/1 Vk4tg 15.19 6 1.71 13.20 6 3.70
VH12f/B1-8f Vk4tg 6.96 6 1.90‡ 11.20 6 2.53*
The number of B lymphocytes is estimated by anti-B220 and anti-IgM
staining of splenic and peritoneal cavity cells in flow cytometry analyses.
Mice analyzed were kept in a conventional animal facility and were 2–4
mo old. Groups of more than three mice were analyzed for each geno-
type.
*Greater than 90% of the B cells express only VH12 (see Fig. 4).
‡Approximately 50% of the B cells are single VH12 expressors (see Fig. 3).476 BCR Specificity and Surface Density in B-1 Cell Development
ligand-mediated clonal expansion, as VH12 together with
Vk4 recognizes PtC (8). Again, this expansion is modu-
lated in VH12/B1-8f, Vk4tg mice (Table I). The three- to
fivefold increase in the number of splenic B cells in this
mouse strain compared with Vk4tg or B1-8f/1, Vk4tg
mice is probably due to the fact that .50% of these cells in
VH12f/B1-8f, Vk4tg mice are single VH12 expressors (Fig. 3).
Discussion
VH12 insertion mice, like conventional VH12 transgenic
mice (8), generate mostly B-1 cells, whereas VHB1-8 and
VHglD42 insertion mice produce predominantly conven-
tional, or B-2, cells. This is in line with the concept that
BCR specificity is a major determinant in B-1 versus B-2
cell development. The novel findings in this study are that
the coexpression of VH12 with either of the two other VH
region genes in double IgH insertion mice (which express
wild-type k chains or a Vk4 transgene) results in the gener-
ation of a population of double-producing B-2 cells. In ad-
dition, in such animals a population of single-producing B
cells appears, namely, B-1 cells expressing only VH12.
Why do VH12-expressing B cells that coexpress a second
H chain not differentiate into B-1 cells? This can perhaps,
best be explained by postulating that signaling via a BCR of a
certain specificity, expressed at the cell surface at high density,
is required to drive the differentiation of B cells into the B-1
subset. In our experiments, the provision of a second H chain
of a different specificity presumably acts in a “dominant-neg-
ative” manner to dilute out the VH12-containing BCR com-
plexes on the cell surface. Assuming equivalent production of
H chains from the various inserted VHDHJH segments and
equivalent pairing of the H and L chains involved, only 25%
of the Ig molecules on the cell surface of double-producing
cells would carry VH12 regions on both H chains. This re-
duced density of B-1–specific BCRs may not provide suffi-
cient signal for the development of B-1 phenotype.
The hypothesis that BCR signaling is responsible for the
development of the B-1 cell phenotype has been supported
by experiments that show that under certain conditions the
cross-linking of sIg on splenic B cells may lead to develop-
ment of a B-1 cell phenotype on B-2 cells (20). The
skewed development of B-1 and B-2 cell subsets in many
gene-targeted mice with mutations in specific signaling
molecules is also consistent with this hypothesis. For exam-
ple, CD19-deficient mice (21, 22) and xid (23) mice that
have a mutation in the btk gene have reduced numbers and
a lack of B-1 cells, respectively. In contrast, lyn-deficient
mice (24, 25) and motheaten mice that have a mutation in
SHP-1 (26) have increased numbers of B-1 cells. More sig-
nificantly, the introduction of the xid defect into VH12
conventional transgenic mice leads to the predominance of
VH12-expressing B cells with a B-2 cell phenotype (27),
compared with wild-type VH12 transgenic mice that gen-
erate mostly B-1 cells.
The appearance of large numbers of VH12-expressing B-1
cells in the double mutants that have lost expression of the
second H chain is of particular interest. Such loss variants
are rare in VHB1-8/VHglD42 mice (15), emphasizing the
stability of these targeted IgH loci in B cell development.
This suggests that the VH12-only cells in the present system
are strongly selected, in accord with the concept that B-1
cell development is driven by BCR signaling. It will be of
interest to determine at which stage of development the
loss of the second IgH allele occurs in these cells; and
whether its loss in mature (B-2) double producers will
change their phenotype to that of B-1 cells.
It is apparent that B-2 cell development depends to a
lesser extent than that of B-1 cells on density of BCRs of
certain specificities at the cell surface (reference 15 and the
data presented here). This might reflect a lesser dependence
of B-2 cells on positive selection by (self)-antigens. The re-
quirement of BCR expression for B-2 cell survival (11)
would then largely be a cell-autonomous phenomenon.
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